R&D at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by The Cooper Companies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Cooper Companies, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Cooper Companies, Inc.'s R&D?
- The Cooper Companies, Inc. (COO) reported R&D of $42.5M in Q1 2026.
- How has The Cooper Companies, Inc.'s R&D changed year-over-year?
- The Cooper Companies, Inc.'s R&D decreased by 6.6% year-over-year, from $45.5M to $42.5M.
- What is the long-term trend for The Cooper Companies, Inc.'s R&D?
- Over 4 years (2021 to 2025), The Cooper Companies, Inc.'s R&D has grown at a 16.7% compound annual growth rate (CAGR), from $92.9M to $172.2M.
- What does R&D mean?
- The money spent on developing new products and improving existing ones.
- How do you interpret R&D?
- Consistent or increasing investment is generally positive for long-term competitiveness, whereas significant cuts may signal a focus on short-term profitability at the expense of future innovation.
- How does R&D compare across companies?
- High R&D spend is standard for companies in the healthcare and medical technology sectors to maintain a competitive product pipeline.